~~<i id='9CF03CCB5D'><strike id='9CF03CCB5D'><tt id='9CF03CCB5D'><pre id='9CF03CCB5D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

knowledge

author：explore 2025-10-02 17:22:43 - browse：7531

LONDON — GSK said Tuesday it would purchase the asthma-focused drug developer Aiolos Bio for $1 billion upfront, the latest in a string of pharma acquisitions that are bolstering hopes for the industry’s year ahead.

The deal includes up to another $400 million in payments if certain milestones are met.

Aiolos was launched just last year, based in both San Francisco and London. The company, which announced a $245 million Series A round in October, has been readying a Phase 2 trial of its candidate AIO-001 in adult asthma.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： In utero gene editing: an explainer

leisure time

Wikipedia

focus

hotspot

focus

4:01BarricadesareseenneartheFultonCountycourthouse,Monday,Aug.7,2023,inAtlanta.Thesheriff'sofficeare

WSS

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Alabama frozen embryo ruling has major implications for IVF clinics

Astronauts get first look at the spacecraft that will fly them around the moon

Medicare inequities exacerbate Puerto Rico’s health disparities

In venture capital firm's success, lessons for turning crisis into profit

PBM reform efforts get punted in Congress

entertainment

knowledge

leisure time

State Dept. review finds Biden bears some blame for Afghanistan failures

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Activists slam private health insurers over coverage restrictions

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Medicare proposal to cover medical devices draws a mixed reaction

NIH study of ME/CFS points to clear biological hallmarks

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Sports medicine is finally prioritizing gender equality

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

Wikipedia

STAT readers on older presidents, polypills, Medicare, and more

A new nitrogen execution bill also undermines medical licensing

PBM reform efforts get punted in Congress

In utero gene editing: an explainer

Mega Millions jackpot estimated at record $1.58 billion for Tuesday's drawing

R1 RCM gets $5.8 billion buyout offer from private equity firm

focus

hotspot

hotspot

focus